Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cbdmd Inc (NY: YCBD )

0.1950 -0.0010 (-0.51%)
Official Closing Price Updated: 8:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 91,705
Open 0.2000
Bid (Size) 0.1800 (1)
Ask (Size) 0.1970 (188)
Prev. Close 0.1960
Today's Range 0.1900 - 0.2000
52wk Range 0.1558 - 1.130
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
cbdMD™ Makes History Becoming the First CBD Brand to Achieve 3 NSF’s Certified for Sport® Certifications
From cbdMD, Inc.
Via Business Wire

Performance

YTD
-15.40%
-15.40%
1 Month
-19.42%
-19.42%
3 Month
-14.10%
-14.10%
6 Month
-13.37%
-13.37%
1 Year
-81.25%
-81.25%

More News

Read More
cbdMD to Present at NutraIngredients-USA's Sports and Active Nutrition Summit
Via Newsfile
cbdMD Q1 Net Sales Decline 35% YoY, What About Net Loss?
Via Benzinga
cbdMD Posts $15 Million in Net Income Improvement over Prior Year Quarter
Via Newsfile
cbdMD Receives $1 Million Return of Capital Following Closing of Adara SPAC Transaction
Via Newsfile
cbdMD, Inc. to Host Conference Call to Discuss First Quarter of Fiscal 2023 Results
Via Newsfile
cbdMD Maintains Commitment to Advocating for FDA Regulation Despite Recent News
Via Newsfile
Exposures Product Safety
Earnings Scheduled For February 13, 2023
Via Benzinga
Key Marijuana Executive Changes You Should Know About: This Company Got A New CEO & More News
Via Benzinga
cbdMD Welcomes Shannon Charles as Chief Marketing Officer
Via Newsfile
Why Shares of Chinese Companies Are Trading Higher? Here Are 55 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
cbdMD Continues to Drive Operational Improvement
Via Newsfile
Earnings Scheduled For December 15, 2022
Via Benzinga
cbdMD, Inc. to Host Conference Call to Discuss Fourth Quarter and Fiscal 2022 Results
Via Newsfile
cbdMD Successfully Launches Into a Growing Japanese Market
Via Newsfile
cbdMD's Broad Spectrum Hemp Extract Reduces Pain In Healthy Adults, Clinical Study Inital Results Confirm
Via Benzinga
cbdMD'S Human Clinical Study Demonstrates Strong Pain Benefits
Via Newsfile
Exposures Product Safety
cbdMD to Present at ThinkEquity Conference on October 26, 2022, in New York City
Via Newsfile
cbdMD Launches Powerful New Product Designed to Reduce Pain - cbdMD MAX
Via Newsfile
cbdMD Announces Strategic Launch of Strongest CBD at the Best Value
Via Newsfile
Why Avenue Therapeutics Is Trading Lower By 59%; Here Are 31 Stocks Moving Premarket
Via Benzinga
Why Laser Photonics Shares Surged By Around 19%; Here Are 70 Biggest Movers From Friday
Via Benzinga
CBD Products Soon On Shelves Of Wegmans Supermarkets Via Partnership With cbdMD
Via Benzinga
cbdMD Launches Line of CBD Products with Wegmans Food Markets
Via Newsfile
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.